Yoon Hai-Jeon, Kim Yemi, Chang Kyu-Tae, Kim Bom Sahn
Department of Nuclear Medicine, Ewha Womans University School of Medicine, 911-1 Mok-Dong, Yangchun-ku, Seoul, 158-710, Republic of Korea,
Ann Nucl Med. 2015 Aug;29(7):553-60. doi: 10.1007/s12149-015-0977-3. Epub 2015 May 5.
This study investigated the prognostic value of preoperative breast-specific gamma imaging (BSGI) uptake measured by a semi-quantitative method in invasive ductal carcinoma (IDC).
One hundred and sixty-two women with IDC who underwent preoperative BSGI were retrospectively enrolled. The tumor-to-normal tissue ratio (TNR) was measured on BSGI and correlated with histologic prognostic factors. The prognostic impact of TNR was tested with regard to progression-free survival (PFS) and compared with established prognostic factors.
High TNR was significantly correlated with tumor size >2 cm (p < 0.001), high nuclear grade (p = 0.04), high histologic grade (p = 0.01), axillary node positivity (p = 0.04), ER negativity (p = 0.03), HER2 positivity (p = 0.01), and high MIB-1 index (p = 0.001). Among 162 patients, 14 experienced recurrence during mean follow-up time of 34.7 ± 14.9 months. In Kaplan-Meier survival analyses, high TNR (p < 0.001), high nuclear grade (p = 0.02), high histologic grade (p = 0.007), ER/PR negativity (p = 0.003 and p < 0.001, respectively), HER2 positivity (p = 0.01), triple negativity (p = 0.02), and high MIB-1 index (p = 0.02) showed a significant relationship with poor prognosis. Among them, high TNR was an independent poor prognostic factor in a multivariate regression analysis (p = 0.01).
High BSGI uptake measured by a semi-quantitative method was correlated with diverse poor histologic prognostic factors and was an independent poor prognostic factor in invasive ductal cancer.
本研究探讨通过半定量方法测量的术前乳腺特异性γ成像(BSGI)摄取在浸润性导管癌(IDC)中的预后价值。
回顾性纳入162例接受术前BSGI检查的IDC女性患者。在BSGI上测量肿瘤与正常组织比值(TNR),并将其与组织学预后因素相关联。就无进展生存期(PFS)测试TNR的预后影响,并与既定的预后因素进行比较。
高TNR与肿瘤大小>2 cm(p < 0.001)、高核分级(p = 0.04)、高组织学分级(p = 0.01)、腋窝淋巴结阳性(p = 0.04)、雌激素受体阴性(p = 0.03)、人表皮生长因子受体2阳性(p = 0.01)和高MIB-1指数(p = 0.001)显著相关。在162例患者中,14例在平均随访时间34.7±14.9个月期间出现复发。在Kaplan-Meier生存分析中,高TNR(p < 0.001)、高核分级(p = 0.02)、高组织学分级(p = 0.007)、雌激素受体/孕激素受体阴性(分别为p = 0.003和p < 0.001)、人表皮生长因子受体2阳性(p = 0.01)、三阴性(p = 0.02)和高MIB-1指数(p = 0.02)与预后不良显著相关。其中,高TNR在多因素回归分析中是独立的不良预后因素(p = 0.01)。
通过半定量方法测量的高BSGI摄取与多种不良组织学预后因素相关,并且是浸润性导管癌的独立不良预后因素。